HLTH 250 Lecture Notes - Lecture 17: Danish International Development Agency, Unitaid, Rockefeller Foundation
![](https://new-preview-html.oneclass.com/lAX98ZbWJYdojKx4GMqLNn0grqyDPwa7/bg1.png)
11/20/17
Monday, November 20, 2017
10:02 AM
Application of health economics in global health
Joseph D. Njau
• Key global health players
• WHO: established in 1948 w objective of attaining highest level ofhealth for all the ppl
worldwide
• World bank: nutrition, population, HIV/AIDS, malaria, maternal and child healhtprograms
o These werent there at the time world bank was invisioned. Over time we see these
social services
• Global fund (`2000)
• GAVI mostly to improve vaccine uptake and new vaccine introductions
• UNITAID for HIV/AIDS, tuberculosis and malaria
• Other UN organizations including UNDP, UNICEF, UNHCR, UNAIDS
• Bilateral organizations like USAID, DFID, IDRC, JICA, AUSAID, DANIDA, etc
• Private organizations: bill and melinda gates foundation, wellcome trust, institute pasteur,
rockefeller foundation, and others
• Global health success stories
• Smallpox eradication in 1980
• Mobilization of resources to combat hiv/aids in 1990
• Malaria and tb back on the agenda
• Polio at the verge of global elimination (only 14 cases worldwide)
o Cases are being seen in places that are politically unstable (nigeria, afghanistan,
somalia)
o Syria has seen some polio strains
• Global elimination of guinea worms: carter center
• Mobilization of global resources to fight NTDs
• Health systems reforms
• Universal health care access on the global agenda
o Worldwide improvement of maternal and child health
o Everybody should be able to get these services
• Challenges
• Mismatch between resources and global health needs
o We have em but you need to pull a lot of resources in order to approach the needs
o Finding a away to insure everybody is real hard
• Uncertainty of global health agenda caused by unreliable funding sources and funding
politics
o Bc theres no money, only the diseases that rich kids care about are worked on, not
NTDs
• Moral hazard caused by funding conditions such as the setup of parallel funding mechanism
for public health programs
o We hae resoures for alaria ad hi, ut e do’t hae eough fudig for the to
work on everything else
• The only place theyre assured pay is hiv, so malaria is neglected
• Disproportional funding allocations across regions and programs
find more resources at oneclass.com
find more resources at oneclass.com
Document Summary
Full evaluation (costs and outcomes: cost benefit analysis (cba) or benefit cost analysis (bca, cost effectiveness analysis (cea, cost utility analysis (cua) in health, cost of illness, estimates total costs incurred because of a disease or condition. Includes hospital and non hospital medical costs, productivity losses: ex. How many resources are we using on patients of malaria health impact. Sickness: deaths, people left w long term sequalae, economic impact, productivity loss from death or disability affected population, productivity loss of caregivers. Loss of travel/transport bans, consumer confidence and spending, absenteeism and closure of schools, cost of response and recovery. Social impact: disrupition of social fabric, children left w/out caregivers, disruption of households, need for more caregivers due to disability. Social stigma: equity access issues, women and children, poorest are disproportionately affected, health economics (rubella case study, resources are scarce. In econ, a resources cost is the sascrifice necessary to obtain goods or sercices like volunteer time, donated space, etc.